Literature DB >> 9298273

Spinal cord astrocytomas: long-term results comparing treatments in children.

G J Przybylski1, A L Albright, A J Martinez.   

Abstract

Technology enabling radical resection has expanded treatment options for children with spinal cord astrocytomas. Comparison of long-term survival and neurological function after complete tumor removal with more conservative treatment may determine whether radical surgery can improve outcome in well-differentiated and anaplastic spinal cord astrocytomas. In all, 18 children with spinal cord astrocytomas were initially treated between 1976 and 1992 with biopsy in 6, subtotal removal in 7, and complete resection in 5. Seven had anaplastic tumors. Nine children treated before 1988 received radiotherapy. Survival after a median follow-up of 11 years was 82% (9/11). Five patients with anaplastic tumors are alive between 12 and 18 years after treatment. No patient relapsed after total resection, whereas more than two-thirds treated with other than complete resection relapsed within 3 years (P = 0.029). All but 1 patient with symptomatic relapse received radiotherapy (P = 0.059). Magnetic resonance imaging more than 3 years postoperatively showed no recurrences in 13 of the 15 survivors and asymptomatic progression in the other 2. Although excellent long-term survival was seen, frequent relapse was associated with either incomplete resection or radiotherapy. Prolonged relapse-free survival was observed in all patients treated with complete resection, including 3 with anaplastic tumors.

Entities:  

Mesh:

Year:  1997        PMID: 9298273     DOI: 10.1007/s003810050103

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

1.  The influence of central review on outcome in malignant gliomas of the spinal cord: the CCG-945 experience.

Authors:  Eric Bouffet; Jeffrey C Allen; James M Boyett; Allen Yates; Floyd Gilles; Peter C Burger; Richard L Davis; Laurence E Becker; Ian F Pollack; Jonathan L Finlay
Journal:  J Neurosurg Pediatr       Date:  2015-12-18       Impact factor: 2.375

Review 2.  Prognostic factors in intramedullary astrocytomas: a literature review.

Authors:  Vladimír Benes; Pavel Barsa; Vladimír Benes; Petr Suchomel
Journal:  Eur Spine J       Date:  2009-06-28       Impact factor: 3.134

Review 3.  Primary and metastatic glioblastoma of the spine in the pediatric population: a systematic review.

Authors:  Runze Yang; Albert M Isaacs; Magalie Cadieux; Tomas J Hirmer; Travis S CreveCoeur; Andrew P Lapointe; Michael Opoku-Darko; Zahra Premji; Jay Riva-Cambrin; Clare N Gallagher
Journal:  Childs Nerv Syst       Date:  2021-03-06       Impact factor: 1.475

4.  Prognostic factors and survival in primary malignant astrocytomas of the spinal cord: a population-based analysis from 1973 to 2007.

Authors:  Hadie Adams; Javier Avendaño; Shaan M Raza; Ziya L Gokaslan; George I Jallo; Alfredo Quiñones-Hinojosa
Journal:  Spine (Phila Pa 1976)       Date:  2012-05-20       Impact factor: 3.468

5.  Hypofractionated radiotherapy boost for dose escalation as a treatment option for high-grade spinal cord astrocytic tumor.

Authors:  Norio Katoh; Hiroki Shirato; Hidefumi Aoyama; Rikiya Onimaru; Keishiro Suzuki; Kazutoshi Hida; Kazuo Miyasaka; Yoshinobu Iwasaki
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

Review 6.  Chemotherapy for intramedullary spinal cord tumors.

Authors:  C Balmaceda
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

7.  Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.

Authors:  Mohamad H Fakhreddine; Anita Mahajan; Marta Penas-Prado; Jeffrey Weinberg; Ian E McCutcheon; Vinay Puduvalli; Paul D Brown
Journal:  Neuro Oncol       Date:  2013-01-14       Impact factor: 12.300

8.  Pediatric primary intramedullary spinal cord glioblastoma.

Authors:  Robert Lober; Suash Sharma; Beverly Bell; Alan Free; Ramon Figueroa; Chris W Sheils; Mark Lee; John Cowell
Journal:  Rare Tumors       Date:  2010-09-30

9.  Clinical outcomes and a therapeutic indication of intramedullary spinal cord astrocytoma.

Authors:  Narihito Nagoshi; Osahiko Tsuji; Satoshi Suzuki; Satoshi Nori; Mitsuru Yagi; Eijiro Okada; Hajime Okita; Nobuyuki Fujita; Ken Ishii; Morio Matsumoto; Masaya Nakamura; Kota Watanabe
Journal:  Spinal Cord       Date:  2021-07-26       Impact factor: 2.772

10.  Lumbosacral glioblastoma and leptomeningeal gliomatosis complicating the course of a cervicothoracic astrocytoma WHO grade II.

Authors:  Daniel Klase; Stefan Gottschalk; Erich Reusche; Christian Hagel; Einar Goebel; Volker Tronnier; Alf Giese
Journal:  Childs Nerv Syst       Date:  2007-04-14       Impact factor: 1.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.